By the Top Tier Newswire AI Desk · August 10, 2026 at 10:03 AM ET · reviewed against 4 wire stories
DOXIMITY INC A (DOCS) is down -7.07% in the latest session. Our newswire has captured 4 stories on DOCS across 3 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
DOCS stock fell 7.07% to $25.46 on Friday amid a downgrade from Wells Fargo, which cut the stock to Underweight from Equal Weight. The move reflects concerns over the company's valuation and comes after a volatile intraday session that saw the stock open higher but then decline sharply throughout the day.
What Happened
Wells Fargo initiated the downgrade, citing valuation concerns as the primary reason. The firm maintained a price target of $18 for the stock, signaling a bearish outlook. The downgrade followed Doximity’s first-quarter earnings report, which showed revenue of $157 million, up 7% year-over-year. However, the firm’s updated rating appears to weigh more heavily on investor sentiment than the earnings results. The stock opened at $27.58, a modest 0.7% gap up from the prior close, but quickly reversed course and hit an intraday low of $24.36. By the close, the stock had settled at $25.46, with 2.3 million shares traded, 0.6 times the 3-month average. The sell-off was notable given the recent 16.9% rise in the stock over the previous eight sessions.
What The Data Shows
The stock’s fundamentals remain mixed. It trades at a P/E of 32.5, with revenue growing 11.2% in the trailing twelve months and a net margin of 25.5%. However, the 52-week range of $17.15 to $76.51 highlights the stock’s volatility. Recent insider transactions also show a pattern of selling, with the Chief Accounting Officer, Sitaram Siddharth, selling shares on three separate occasions in the past 90 days. No unusual options activity or significant social chatter has been reported, and retail traders on r/wallstreetbets have expressed mixed views, with some calling the stock oversold and others suggesting more upside could be possible.
What To Watch
The stock is set to continue under the microscope as investors assess the validity of the downgrade and whether the valuation concerns are justified. No upcoming earnings date is listed, but coverage breadth and analyst sentiment will be key to watch in the coming weeks.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Wells Fargo downgrades Doximity stock rating on valuation concerns
Wells Fargo downgrades Doximity stock rating on valuation concerns
11h agoThe FlyBEARISH 38Analyst
Doximity Downgraded To Underweight From Equal Weight At Wells Fargo
2d agoYahoo FinanceBULLISH 73General
Why Doximity Stock Skyrocketed on Friday
The leading digital platform for U.S. medical professionals is becoming a formidable force in the AI race.
2d agoYahoo FinanceBULLISH 63Earnings
Doximity Q1 Earnings Call Highlights
Doximity (NYSE:DOCS) reported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year earlier, as the company cited improving demand from pharmaceutical and hospital customers and increased engagement with its clinical artificial intelligence tools. Adjusted EBITDA totaled $75 million,
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →